Prostate cancer. Malignant neoplasm of prostate
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria :willingness to participate in the study; completing written informed consent;no history of prostate cancer and benign prostatic hyperplasia; age of 50 to70 and lack of severe vision and hearing impairment. exclusion criteria : absence in training sessions ; participation in similar training courses.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Knowledge. Timepoint: One month after the intervention. Method of measurement: Prostate Cancer Screening Knowledge Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Health Belief Model component. Timepoint: One month after the intervention. Method of measurement: HBM questionnaire screening for prostate cancer.;Screening behavior. Timepoint: One and three months after intervention. Method of measurement: Participation in free screening programs. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences